Your browser doesn't support javascript.
loading
Eggerthella lenta bacteremia successfully treated with ceftizoxime: case report and review of the literature.
Jiang, Shuming; E, Jianfei; Wang, Dengchao; Zou, Yanjiao; Liu, Xiao; Xiao, Hualiang; Wen, Yuan; Chen, Zongyao.
Afiliação
  • Jiang S; Pathology Department, People's Hospital of Deyang City, Deyang, China.
  • E J; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Wang D; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Zou Y; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Liu X; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Xiao H; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Wen Y; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China.
  • Chen Z; Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, China. chenzyao@yeah.net.
Eur J Med Res ; 26(1): 111, 2021 Sep 20.
Article em En | MEDLINE | ID: mdl-34544476
ABSTRACT
Eggerthella lenta is a normal human microflora that is anaerobic, non-sporulating, and Gram positive. However, an increasing number of studies have shown that it could also be an important pathogen for humans, even causing life-threatening infection under certain conditions. However, understanding its pathogenic mechanism and treatment options still need to be improved; more clinical data are needed to explore it further. In this article, we report a case of ceftizoxime-cured E. lenta bacteremia and review the recent literature to provide more clinical data for the diagnosis of E. lenta bacteremia. Our report suggests that the frequency of E. lenta bacteremia is increased in patients with hematologic or solid organ cancer, diabetes mellitus and also in those with appendicitis.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftizoxima / Bacteriemia / Actinobacteria / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Eur J Med Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ceftizoxima / Bacteriemia / Actinobacteria / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Adult / Humans / Male Idioma: En Revista: Eur J Med Res Ano de publicação: 2021 Tipo de documento: Article